PharmaCyte Biotech, Inc.

Q4 2022 13F Holders

Symbol
PMCB
CUSIP
71715X203
Type
Equity
Class
COM NEW
Num filings
38
Total reported value, excl. options
$10.1 M
Manager Report Date Value ($000) Shares Option Type